GlassScriptPhysician profile
Luke C Jeffries
NPI 1639360381
$322.15
in general payments reported to CMS, 2019-2025
13 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.64 · 2020: $30.58 · 2022: $15.15 · 2023: $55.99 · 2024: $37.94 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $38.90 | 2025 | Integraendoscopic Gastro Release System, Memofix Super Elastic Nitinol Staple System, Vlp Mini-Mod |
| Integra Lifesciences Corporation | $36.09 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $35.83 | 2020-2023 | Puraply |
| Merck Sharp & Dohme LLC | $32.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.99 | 2022-2023 | Seglentis |
| Melinta Therapeutics, LLC | $24.00 | 2019 | |
| Kci USA, INC. | $23.46 | 2023 | Activ.A.C. Ion Progress, Promogran Prisma |
| Polaris Technology Solutions LLC | $21.36 | 2025 | |
| Solventum Corporation | $19.22 | 2024 | V.A.C.Ulta |
| Next Science LLC | $18.72 | 2024 | Surgx, Blastx, Xperience |
| Bioventus LLC | $16.50 | 2025 | Exogen Ultrasound Bone Healing System |
| Medtronic Vascular, INC. | $14.44 | 2020 | |
| Convatec INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Jeffries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.